Endpoints News
BeOne pipeline cuts Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
M T W Thu F
7 May, 2026
US Pharma and Biotech Summit - May 14, 2026
Just announced: A senior FDA official joins the conversation at the US Pharma & Biotech Summit. Policy shifts, regulatory unknowns, a dealmaking environment that won't sit still — join FT Live and Endpoints News for the conversations that will define what comes next.
presented by Biocon
Bio­con’s Bold In­te­gra­tion: Uni­fy­ing Biosim­i­lars and Gener­ics to Re­de­fine Glob­al Af­ford­able Ac­cess
news
Angelini fortifies neurology portfolio with $4.1B buyout of Catalyst
ENDPOINTS NEWS
BeOne culls five cancer programs and an autoimmune Phase 2
ENDPOINTS NEWS
Amgen, AbbVie say IRA negotiations impacted Q1 sales
ENDPOINTS NEWS
Endpoints webinars
May 12
10:30 am ET
Rules of engagement: How G3BP2 paves the way to rationalize novel degrons
Thermo Fisher
May 20
11:00 am ET
Application of Simple Western to analysis of antibody target affinity and specificity
Bio-Techne
ENDPOINTS at #ASCO26
ASCO is about to deliver some make-or-break cancer data. Join us to figure out which pipeline bets will pay off. Get your spot now.
ENDPOINTS PHARMA
Lonza looks to ride ADC wave with upcoming factory, workforce expansion
ENDPOINTS NEWS
Novo Nordisk's first quarter in four words: Pills, pricing, payments and pressure
ENDPOINTS NEWS
Lilly allots $4.5B for new manufacturing projects across Indiana
ENDPOINTS NEWS
in case you missed it
1.
GSK goes to China for $1B siRNA deal in Arrowhead's obesity lane
ENDPOINTS NEWS
2.
Bayer dips toes back into pharma M&A to buy Perfuse Therapeutics
ENDPOINTS NEWS
3.
Exclusive: Startup aims to lift mRNA out of purgatory with more durable therapies
ENDPOINTS NEWS
4.
CellCentric raises $220M to get multiple myeloma pill to market
ENDPOINTS NEWS
5.
Avalo scores much-needed Phase 2 win and $375M raise as it attempts turnaround
ENDPOINTS NEWS
6.
News Briefing
Madrigal MASH drug beats expectations; Gilead cuts jobs; investment firm debuts
ENDPOINTS NEWS
7.
Eli Lilly kicks off high-grade bond sale in push to fund deals
BLOOMBERG
8.
Global crackdown on illicit pharmaceuticals sees $15.5M in seizures
REUTERS
Reynald Castaneda
.

Just announced: A senior FDA official is joining us at the US Pharma & Biotech Summit next week. US biopharma still leads the world in high-risk drug development, but the road from innovation to access has never been harder to predict. You won't want to miss this conversation. Join us virtually or in NYC here.

.